GlaxoSmithKline PLC at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) Transcript
This presentation is for Bank of America clients only. If you are a member of the media or the press, please disconnect now.
Okay. Good morning, everybody, and welcome to day 2 of the Bank of America Global Healthcare Conference. For those of you who don't know me, I'm Graham Parry, one of the European pharma analysts here at Bank of America. And I'm very pleased today to be able to introduce our first company and, in particular, Emma Walmsley, the CEO of GlaxoSmithKline.
As with the session yesterday, if you have any questions, then please enter them directly into the Veracast website and I'll ask them. Alternatively, if you're having any technical difficulties with that, then you can also e-mail them through to me at [email protected].
So Emma, welcome to the conference. Shame we couldn't see you in person, but I think this is the closest that we can get. And perhaps I'll just kick off the -- our fireside chat
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |